List of insiders holdings for Prelude Therapeutics Inc:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| 1 | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC ORBIMED CAPITAL LLC OrbiMed Genesis GP LLC Director 10% Owner | 2026-04-23 20:42:51 | 12,935,071 0 | 12,935,071 | Form 13D |
| 2 | Vaddi Krishna CEO | 2026-02-13 16:02:12 | 6,745,647 0 | 6,745,647 | Form 13G |
| 3 | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Shah Rajeev M. 10% Owner | 2026-04-28 17:16:19 | 6,477,309 0 | 6,477,309 | Form 13G |
| 4 | Brusky Sean P. Chief Business Officer | 2026-03-19 19:39:30 | 850,000 0 | 850,000 | Form 3 |
| 5 | Morris Charles Q Chief Medical Officer | 2026-05-04 16:10:00 | 450,000 0 | 450,000 | Form 4 |
| 6 | Lim Bryant David CLO, CFO, Corp Sec. | 2026-02-05 16:11:32 | 275,000 0 | 275,000 | Form 4 |
| 7 | Piper Brian Chief Financial Officer | 2021-08-27 20:02:38 | 264,329 0 | 264,329 | Form 4 |
| 8 | Scherle Peggy Chief Scientific Officer | 2026-02-05 16:12:45 | 230,000 0 | 230,000 | Form 4 |
| 9 | Combs Andrew Chief Chemistry Officer | 2026-02-05 16:14:15 | 230,000 0 | 230,000 | Form 4 |
| 10 | Pierce Christopher EVP and Chief of Business Oper | 2021-09-07 19:17:05 | 211,546 0 | 211,546 | Form 4 |
| 11 | Chardonnet Laurent Chief Financial Officer | 2024-03-04 18:04:08 | 150,000 0 | 150,000 | Form 4 |
| 12 | Mauro David J Chief Medical Officer | 2021-10-06 18:02:41 | 137,610 0 | 137,610 | Form 4 |
| 13 | Huang Jane President, CMO | 2025-10-07 07:05:37 | 105,667 0 | 105,667 | Form 4 |
| 14 | Morosini Deborah EVP, Chief of Clinical Affairs | 2022-02-17 19:08:46 | 90,000 0 | 90,000 | Form 4 |
| 15 | BAKER BROS. ADVISORS LP 667 L.P. Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Director 10% Owner | 2026-06-10 16:44:44 | 0 76,000 | 76,000 | Form 4 |
| 16 | Dier Mardi Director | 2025-06-13 16:15:27 | 38,000 0 | 38,000 | Form 4 |
| 17 | FRIEDMAN PAUL A Director | 2026-06-10 16:12:25 | 38,000 0 | 38,000 | Form 4 |
| 18 | Sandor Victor Director | 2026-06-10 16:13:05 | 38,000 0 | 38,000 | Form 4 |
| 19 | Bonita David P Director 10% Owner | 2026-06-10 16:13:51 | 38,000 0 | 38,000 | Form 4 |
| 20 | Babler Martin Director | 2026-06-10 16:15:10 | 38,000 0 | 38,000 | Form 4 |
| 21 | Dorton Katina Director | 2026-06-10 16:15:43 | 38,000 0 | 38,000 | Form 4 |
| 22 | Scherer Paul C Director | 2025-06-13 16:43:00 | 0 0 | 0 | Form 3 |
| 23 | Neu Kelvin Director | 2020-09-24 19:29:37 | 0 0 | 0 | Form 3 |